Anticipated cost savings, including a net workforce reduction of approximately 27% in 2025, support company operations into 1H 2027 and through anticipated, first commercial launch in the U.S.
All entries for: Intellia Therapeutics
January 9, 2025
Intellia Therapeutics
Layoffs
Cambridge, MA
501-1,000 employees
Disease Area: Rare Diseases
Drug Type: Biologic, Small Molecule
